COVID-19: Most Read Stories From 2024
Drug Topics
DECEMBER 24, 2024
Check out this list of our top 5 most read COVID-19 stories from the year 2024.
Tue.Dec 24, 2024
460 
Study: Shingles Could Significantly Increase Risk of Dementia and Parkinson Disease
Pharmacy Times
DECEMBER 24, 2024
Researchers recommend early vaccination against herpes zoster to mitigate the risks.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Giving Pharmacists Prescriptive Authority for Glucagon Would Benefit Patients with Diabetes
Drug Topics
DECEMBER 24, 2024
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences, discuses the benefits of glucagon.
Merry Christmas!
OctariusRx
DECEMBER 24, 2024
Merry Christmas! Thank you to our clients, family, and friends for all your support this year. Our entire team is grateful for our blessings and the wonderful people we work with. Whether you joined us this December, or have been with us for many years, thank you for allowing us to take care of you. We appreciate your trust and support. A successful year would be impossible without our hardworking team.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Dupilumab Lowers Incidence of Psychiatric and Sleep Disorders in Patients With Atopic Dermatitis
Pharmacy Times
DECEMBER 24, 2024
The monoclonal antibody demonstrates the ability to reduce the incidence and improve symptoms related to sleep disorders and psychiatric disorders such as anxiety.
Where do we stand with clinical trial digitalisation?
pharmaphorum
DECEMBER 24, 2024
Discover the current status of digitalisation in clinical trials and its impact on the industry. Explore the progress and challenges of moving towards digitised clinical trial processes.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Novo gets the green light for once-daily haemophilia drug following setbacks
Pharmaceutical Technology
DECEMBER 24, 2024
The FDA initially rejected the marketing application for Alhemo in 2022, asking for additional data on dosing and monitoring.
RECAP: 2024 Updates in the GLP-1 Space
Pharmacy Times
DECEMBER 24, 2024
Despite the explosion of public interest in these drugs, ongoing shortages and debates over compounding made access difficult.
Sanofi takes SK Bio-partnered pneumococcal shot into phase 3
pharmaphorum
DECEMBER 24, 2024
Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines.
Mild IVIG-Related Adverse Events Are Frequent in Children, With Serious Reactions Possible
Pharmacy Times
DECEMBER 24, 2024
Factors associated with intravenous immunoglobulin (IVIG)-related adverse events include older age, dehydration, and administration of multiple IVIG infusions.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Transforming autoimmune disease therapy: Post-ACR 2024 perspectives on cell therapies
pharmaphorum
DECEMBER 24, 2024
Explore the latest perspectives on cell therapies for autoimmune disease treatment post-ACR 2024 and how they are transforming therapy options.
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
Pharmacy Times
DECEMBER 24, 2024
In this episode of Public Health Matters, Christina Madison discusses the concept of reproductive justice and ensuring Black maternal health efforts are not left behind with Regina Davis Moss of In Our Own Voice.
FDA approves flurry of drugs ahead of holiday season
pharmaphorum
DECEMBER 24, 2024
The FDA has wrapped up a series of new approvals as 2024 draws to a close, with Novo Nordisk, Pfizer, Vertex, and Hikma among the beneficiaries.
ASHP Midyear: Appropriate Use of High-Cost IVIG Therapy for BK Nephropathy Needs Further Studying
Pharmacy Times
DECEMBER 24, 2024
Pharmacists are encouraged to work closely with health care providers to ensure appropriate use of high-cost Intravenous immunoglobulin (IVIG) therapy for BK nephropathy.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
AZ gets EU okay for Tagrisso in early-stage lung cancer
pharmaphorum
DECEMBER 24, 2024
AstraZeneca's EGFR inhibitor Tagrisso has become the first drug in the class to be approved in the EU for a form of early-stage lung cancer.
Investigators Find Over 900 Chemicals Can Increase Risk of Breast Cancer
Pharmacy Times
DECEMBER 24, 2024
Of these chemicals, 414 were found to be commonly used in plastics and consumer goods, such as food packaging and personal care products.
XBiotech halts all rheumatology research after missing Phase II endpoints
Pharmaceutical Technology
DECEMBER 24, 2024
XBiotech has said it will investigate the results of its rheumatoid arthritis trial after finding irregularities in its Phase II trial.
Understand the Data on COVID-19 Vaccines and Long COVID
Pharmacy Times
DECEMBER 24, 2024
Patient education on the risks of the long-term illness can help overcome vaccine hesitancy.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
GEMMABio raises $34m to advance gene therapy programmes
Pharmaceutical Technology
DECEMBER 24, 2024
This seed funding comes after GEMMABio secured $100m in October through a partnership with Brazilian supplier Fiocruz.
Advocacy in Action: Opportunities for Oncology Pharmacists in 2025
Pharmacy Times
DECEMBER 24, 2024
Pharmacists bring a unique perspective to health care that bridges clinical knowledge, patient-centered care, and operational expertise.
RAPT Therapeutics and Shanghai Jemincare sign anti-IgE antibody agreement
Pharmaceutical Technology
DECEMBER 24, 2024
RAPT Therapeutics and Shanghai Jemincare Pharmaceutical have signed an exclusive agreement for RPT904 to treat various allergic conditions.
The REAL Reason Pharmacists Hate Vaccines (Not What You Think)
The Happy PharmD
DECEMBER 24, 2024
Pharmacists dont hate giving vaccines. They dont hate helping people. What they hate is being overwhelmed, undervalued, and unable to provide the level of care they know patients deserve. Its easy to misinterpret the challenges pharmacists face when it comes to vaccine administration as something personal. But the reality is much more complicated. The truth is, pharmacists are stretched thin.
AstraZeneca’s Tagrisso gains EC approval for NSCLC treatment
Pharmaceutical Technology
DECEMBER 24, 2024
AstraZeneca has gained approval from the European Commission for its oral therapy, Tagrisso (osimertinib), to treat adults with NSCLC.
FDA Approves Hikma’s Generic GLP-1 Agonist for Type 2 Diabetes
PharmExec
DECEMBER 24, 2024
Approval marks the first generic version of liraglutide injection, referencing Victoza, for improving glycemic control in adults and children aged 10 years and older with type 2 diabetes, alongside diet and exercise.
Pharma Pulse 12/24/24: How Telehealth and Pharma are Partnering to Revolutionize Healthcare, The Influence of Vaping on Smoking Cessation & more
Pharmaceutical Commerce
DECEMBER 24, 2024
The latest news for pharma industry insiders.
Pharma Pulse 12/24/24: Forecasting the 2025 Healthcare Logistics Space, Tech Industry on Cusp of AI Slowdow? & more
PharmExec
DECEMBER 24, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Popular DSCSA Pieces Throughout the Year
Pharmaceutical Commerce
DECEMBER 24, 2024
The Drug Supply Chain Security Act was a major coverage area for Pharma Commerce in 2024.
The Power of AI: Personalized Medicine and Predictive Analytics
PharmExec
DECEMBER 24, 2024
In this part of his Pharmaceutical Executive video interview, Peter Ax, CEO of UpScriptHealth, shares some specific examples of how AI is being used to personalize treatment plans, monitor patient progress, and identify potential issues.
Daiichi and AZ pull Dato-DXd filing in Europe too
pharmaphorum
DECEMBER 24, 2024
AstraZeneca and Daiichi Sankyo have decided to voluntarily withdraw their EU marketing application for Dato-DXd in lung cancer.
How retractions get weaponized on social media
STAT
DECEMBER 24, 2024
Retractions are a sign that science is working as it should. When papers turn out to be flawed, journals typically correct the record to stem the spread of incorrect information and clarify that the other work in their catalogue can be trusted. In just one recent high-profile example, the International Journal of Antimicrobial Agents this week retracted a controversial paper on hydroxychloroquine as an effective treatment for Covid-19 that had drawn ample criticism over methodological and
Opinion: The head of the Catholic Health Association calls for healing of the broken medical system
STAT
DECEMBER 24, 2024
In the wake of the tragic murder of UnitedHealthcare CEO Brian Thompson, all of us who serve in health care must take time to pause and reflect on how we move forward. As a religious sister and leader of the Catholic Health Association of the United States, my reflection on this tragedy has called me to think more deeply about the season of Advent and the meaning of Christmas.
Why bone marrow transplants are becoming less common
STAT
DECEMBER 24, 2024
Blood stem cell transplants have been central players in treating blood cancers for decades. These procedures can improve patients’ chances of survival and can even offer the opportunity for a cure in some cases. But over the last decade, physicians say they’ve started doing transplants for fewer cancer types, particularly lymphomas, and are instead reaching first for newer immune or targeted therapies that are safer and often more effective.
STAT+: 3 trends to watch in telehealth in 2025
STAT
DECEMBER 24, 2024
Midway through 2024, the bottom fell out of telehealth in the United States — or so it felt like to casual observers of the industry. Within a single week, both Walmart and UnitedHealth’s Optum were reported to shut down their virtual care services, closely following the surprise departure of Teladoc’s longtime CEO in April. Telehealth, the rising star of online-first health care set in motion by the necessity of the pandemic, seemed to be in free fall.
Let's personalize your content